XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cashflows - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Jun. 30, 2022
Cash Flows from Operating Activities          
Net increase (decrease) in net assets resulting from operations     $ 2,274,366 $ 6,736,347  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:          
Origination and purchase of investments     (27,986,347) (86,563,667)  
Payment in-kind interest     (540,466) (230,101)  
Sales and repayments of investments $ 15,604,801 $ 45,333,408 32,081,500 66,870,670  
Net realized (gain) loss on investments 0 8,545,020 0 7,783,557  
Net change in unrealized appreciation/depreciation on investments 1,731,840 (9,892,392) 2,410,437 (9,889,537)  
Amortization of discount/premium on investments     (874,796) (1,488,020)  
Amortization of deferred debt issuance costs     346,667 274,444  
Amortization of original issue discount- 2026 Notes 17,778 17,778 35,555 35,555  
Net (increase) decrease in operating assets:          
Interest receivable     379,047 510,613  
Payment-in-kind interest receivable     (14,790) 40,468  
Receivable for investments sold     533,366 5,107,796  
Other receivables     0 0  
Prepaid expenses and other assets     319,502 292,050  
Net increase (decrease) in operating liabilities:          
Payable for investments purchased     (246,984) 23,568,919  
Interest payable     585,804 283,994  
Directors fees payable     1,225 (1,778)  
Accrued expenses and other liabilities     141,009 (394,476)  
Base management fees payable     (109,440) (54,353)  
Income-based incentive fees payable     (147,145) 0  
Net cash (used in) provided by operating activities     9,188,510 12,882,481  
Cash Flows from Financing Activities:          
Payment for deferred financing costs     0 (1,300,000)  
Issuance of common shares     0 3,141,576  
Distributions to stockholders     (4,305,727) (4,197,668)  
Proceeds from borrowing on revolving financing facility     27,400,000 (102,000,000)  
Repayments of borrowing on revolving financing facility     (33,000,000) 115,000,000  
Net cash (used in) provided by financing activities     (9,905,727) 10,643,908  
Net change in cash     (717,217) 23,526,389  
Cash and restricted cash at beginning of year [1]     9,155,077 12,605,203 $ 12,605,203
Cash and restricted cash at end of period $ 8,437,860 [2] $ 36,131,592 [2] 8,437,860 [2] 36,131,592 [2] $ 9,155,077 [1]
Supplemental and non-cash financing cash flow information:          
Cash paid for interest     3,366,541 3,248,088  
Cash paid for taxes     4,330 5,862  
Issuance of shares pursuant to Dividend Reinvestment Plan     10,187 48,098  
Non-cash purchase of investments     65,281 (1,718,794)  
Non-cash sale of investments     $ (65,281) $ 1,718,794  
[1] Represents $2,550,021 and $5,845,249 of unrestricted cash as of December 31, 2022 and December 31, 2021, respectively, and $6,605,056 and $6,759,954 of restricted cash for the same periods
[2] Represents $553,186 and $16,324,330 of unrestricted cash as of December 31, 2022 and December 31, 2021, respectively, and $7,884,674 and $19,807,262 of restricted cash for the same periods .